SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-157914
Filing Date
2024-06-10
Accepted
2024-06-10 08:05:27
Documents
14

Document Format Files

Seq Description Document Type Size
1 DEFA14A d843135ddefa14a.htm DEFA14A 28666
2 GRAPHIC g843135txp10g1.jpg GRAPHIC 403002
3 GRAPHIC g843135txp11g1.jpg GRAPHIC 462667
4 GRAPHIC g843135txp12g1.jpg GRAPHIC 382225
5 GRAPHIC g843135txp13g1.jpg GRAPHIC 405938
6 GRAPHIC g843135txp1g1.jpg GRAPHIC 292256
7 GRAPHIC g843135txp2g1.jpg GRAPHIC 496145
8 GRAPHIC g843135txp3g1.jpg GRAPHIC 387388
9 GRAPHIC g843135txp4g1.jpg GRAPHIC 110163
10 GRAPHIC g843135txp5g1.jpg GRAPHIC 238772
11 GRAPHIC g843135txp6g1.jpg GRAPHIC 431667
12 GRAPHIC g843135txp7g1.jpg GRAPHIC 249090
13 GRAPHIC g843135txp8g1.jpg GRAPHIC 342153
14 GRAPHIC g843135txp9g1.jpg GRAPHIC 460990
  Complete submission text file 0001193125-24-157914.txt   6452944
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36483 | Film No.: 241031511
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)